Publication
Neurocognitive evaluation using the International HIV Dementia Scale (IHDS) and Montreal Cognitive Assessment Test (MoCA) in an HIV‐2 population
dc.contributor.author | Almeida, F | |
dc.contributor.author | Macedo, A | |
dc.contributor.author | Trigo, D | |
dc.contributor.author | Abreu, Miguel | |
dc.contributor.author | Guimarães, M | |
dc.contributor.author | Luís, N | |
dc.contributor.author | Pinho, R | |
dc.contributor.author | Tavares, R | |
dc.date.accessioned | 2023-05-15T10:35:10Z | |
dc.date.available | 2023-05-15T10:35:10Z | |
dc.date.issued | 2021 | |
dc.description.abstract | Objectives: We aimed to characterize neurocognitive impairment (NI) in an HIV-2 population using an observational cross-sectional study in four Portuguese hospitals. Methods: Adult HIV-2-infected patients were included. Montreal Cognitive Assessment Test (MoCA) and International HIV Dementia Scale (IHDS) scales were applied for screening of NI. Patient Health Questionnaire-9 (PHQ-9) and Instrumental Activities of Daily Living (IADL) scales were used for assessment of depression and functionality. A multivariate analysis was performed to assess for risk factors for NI. Results: Eighty-one patients were included, 50.6% of African origin (n = 41) and 49.4% of Portuguese origin (n = 40). The MoCA scale showed alterations in 81.5% of patients (100% of migrants vs. 62.5% of non-migrants, P < 0.001) and the IHDS scale showed alterations in 42%. Both scales were altered simultaneously in 35.8%. Variables independently associated with NI were age [odds ratio (OR) = 0.885] and migrant status (OR = 9.150). Conclusions: Neurocognitive impairment (both scales altered) was present in 35.8%, which is comparable to what is described for HIV-1. The MoCA performed worse in the migrant population and might not be applicable in this setting. | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | Almeida F, Macedo A, Trigo D, et al. Neurocognitive evaluation using the International HIV Dementia Scale (IHDS) and Montreal Cognitive Assessment Test (MoCA) in an HIV-2 population. HIV Med. 2021;22(3):212-217. doi:10.1111/hiv.12963 | pt_PT |
dc.identifier.doi | 10.1111/hiv.12963 | pt_PT |
dc.identifier.issn | 1464-2662 | |
dc.identifier.uri | http://hdl.handle.net/10400.16/2776 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Oxford: Wiley | pt_PT |
dc.relation.publisherversion | https://onlinelibrary.wiley.com/doi/epdf/10.1111/hiv.12963 | pt_PT |
dc.subject | HIV-2 | pt_PT |
dc.subject | HIV-associated neurocognitive disorder | pt_PT |
dc.subject | International HIV Dementia Scale (IHDS) | pt_PT |
dc.subject | Montreal Cognitive Assessment Test (MoCA) | pt_PT |
dc.subject | neurocognitive impairment | pt_PT |
dc.title | Neurocognitive evaluation using the International HIV Dementia Scale (IHDS) and Montreal Cognitive Assessment Test (MoCA) in an HIV‐2 population | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.conferencePlace | England | pt_PT |
oaire.citation.endPage | 217 | pt_PT |
oaire.citation.issue | 3 | pt_PT |
oaire.citation.startPage | 212 | pt_PT |
oaire.citation.title | HIV Medicine | pt_PT |
oaire.citation.volume | 22 | pt_PT |
person.familyName | Vieira Braga de Araújo Abreu | |
person.givenName | Miguel | |
person.identifier.ciencia-id | 5812-146E-1715 | |
person.identifier.orcid | 0000-0001-6999-6641 | |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |
relation.isAuthorOfPublication | 0c2a26b0-8a1e-4c20-8e97-09abcce39e3d | |
relation.isAuthorOfPublication.latestForDiscovery | 0c2a26b0-8a1e-4c20-8e97-09abcce39e3d |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Almeida-2021-Neurocognitive-evaluation-using-the.pdf
- Size:
- 88.97 KB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.35 KB
- Format:
- Item-specific license agreed upon to submission
- Description: